搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
The Lancet
18 小时
Evaluating the benefits of the early use of GLP-1 receptor agonists
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
TCTMD
22 小时
Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?
Surgery is the gold standard, GLP-1s are all the rage—whether a head-to-head study is needed depends on who you ask.
Impacts
5 小时
Understanding the Monthly Cost of Semaglutide: What to Expect
Semaglutide, a medication originally designed to treat type 2 diabetes, has recently gained significant attention as a weight ...
STAT
19 小时
Former Trump health official: Medicare should cover Wegovy — but not negotiate its price
Former Trump administration health official Joe Grogan applauds Biden proposal that Medicare and Medicaid cover GLP-1 ...
Arizona Daily Star
2 小时
Obesity won't be solely defined by BMI under new plan for diagnosis by global experts
New recommendations on how to define obesity would reduce the emphasis on body mass index and take into account health ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈